However, one study revealed that fingolimod increased stress resilience (i.e., prevented stress-evoked depression-like behavior) in a model of chronic unpredictable stress via activation of S1PR3 in the medial prefrontal cortex [19, 21]. Here, S1PR3 is linked to depressive symptom measurement.